InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Belldegrun Arie, Director. Insider active across 4 companies, notably Allogene Therapeutics, Inc.. Aggregated, 9 disclosures have been logged. Total volume traded: €3.4m. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
070,921 shares0
Class A Common Stock
SEC:0000899243-22-022286:0·
04,710,120 shares0
Common Stock
SEC:0001214659-22-004729:0·
04,710,121 shares0
Common Stock
SEC:0001214659-22-004613:0·
€2m155,039 shares@ €11.08520.56% mcap23.3% of flow
Common Stock
SEC:0001214659-22-000701·
Ideal exit: 9 Oct 2022 (T+270)
€2m155,039 shares@ €11.08520.25% mcap23.3% of flow
Common Stock
SEC:0001214659-22-000701:0·
Ideal exit: 9 Oct 2022 (T+270)
€13,7603,241 shares@ €4.24570.0010% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-21-039138·
€13,7603,241 shares@ €4.24570.0010% mcap50.0% of flow
Ordinary Shares
SEC:0001209191-21-039138:0·
€6m379,066 shares@ €14.91651.84% mcap76.7% of flow
Common Stock
SEC:0001214659-21-005878·
€6m379,066 shares@ €14.91650.82% mcap76.7% of flow
Common Stock
SEC:0001214659-21-005878:0·
9 of 9 declarations
About Belldegrun Arie
Arie Belldegrun is a Board Member at Allogene Therapeutics, Inc. and UroGen Pharma Ltd. He plays a key role in the governance of these biopharmaceutical companies, contributing to the definition of their strategy and guiding their research efforts. His expertise in biotechnology is a valuable asset.
